Cabazitaxel (CBZ) in metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (Doc): Single CUP center results

Autor:	N. Agrogianni, D. Gkeka, S. Kaltsas, A. Ntokou, S. Stamatopoulou, D. Zylis, K. Florou, H. Stavrinidis, Alexandros Ardavanis, E. Pouliou, L. Markos
Rok vydání:	2012
Předmět:	Oncology medicine.medical_specialty business.industry Castration resistant medicine.disease Prostate cancer Docetaxel Cabazitaxel Internal medicine medicine Geriatrics and Gerontology Previously treated business medicine.drug
Zdroj:	Journal of Geriatric Oncology. 3:S87
ISSN:	1879-4068
DOI:	10.1016/j.jgo.2012.10.108
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2f6fa64dd84d751c8c2c0bde0d3685a6 https://doi.org/10.1016/j.jgo.2012.10.108 Zobrazit plný text záznamu Full Text from ScienceDirect